Biocon Biologics a fully integrated global biosimilars company and a subsidiary of Biocon Limited Enters a Long-term Commercial Collaboration with Eris Lifesciences to Expand Patient Access in India
This collaboration aims to expand patient access to Biocon Biologics’ Metabolics, Oncology, and Critical Care products portfolio in India. It extends the existing partnership with Eris for Biocon’s Nephrology and Dermatology business.